Report Thumbnail
Product Code IM091461545GGK
Published Date 2022/9/20
English146 PagesGlobal

Smart Healthcare Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027MedicalDevice_MedTech Market


Report Thumbnail
Product Code IM091461545GGK◆The Sep 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2022/9/20
English 146 PagesGlobal

Smart Healthcare Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027MedicalDevice_MedTech Market



Abstract


Summary

The global smart healthcare products market size reached US$ 151.08 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 372.88 Billion by 2027, exhibiting a growth rate (CAGR) of 14.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. Smart healthcare products include an integration of advanced tools and technologies that provide patients with enhanced treatment procedures and improve their quality of life. They are embedded with communication and sensor capabilities as well as data analytics techniques. Smart healthcare products assist in connected medical imaging, telemedicine, outpatient vigilance, etc. In addition to this, they also aid in minimizing the errors related to electronic medical records (EMR), laboratory information systems, computerized physician order entry, etc. Some of the common smart healthcare product include smart syringes, smart pills, smart RFID cabinets, smart wearables, etc. Smart Healthcare Products Market Trends: The growing consumer health consciousness, which has led to the emergence of smart medical devices, including diagnostic and monitoring equipment as well as injury prevention and rehabilitation instruments, is primarily driving the global smart healthcare products market. Furthermore, the rising awareness towards numerous benefits offered by smart healthcare products, such as virtual assistance, improved patient care, user-friendly systems, self-monitoring, etc., is also propelling the market growth. In addition to this, several government authorities are introducing various initiatives to promote the adoption of digital healthcare facilities and to provide accessible medical services across remote areas. For instance, the Indian government has launched the National Digital Health Mission to create a holistic and comprehensive digital health ecosystem that supports universal health coverage. Moreover, the emergence of innovative mHealth mobile apps that allow users to track their fitness levels by observing calorie count, water intake, heart rate, etc., is further augmenting the global market. Apart from this, the increasing inclination towards home care settings for disease management, monitoring, providing feedback, suggesting adequate treatment, etc., on account of the sudden outbreak of the COVID-19 pandemic, is also bolstering the market growth. Additionally, the escalating utilization of cloud-based EMR systems to enable patient's direct involvement throughout the documentation process and provide enhanced protection from data disruption is acting as a significant growth-inducing factor. Furthermore, several technological advancements, including the introduction of the Internet of Things (IoT), artificial intelligence (AI), Big Data, predictive analytics, etc., have improved patient access to services, reduced the operational strain on medical facilities, and provided support for the growth of digital ecosystems across healthcare organizations. This, in turn, is anticipated to propel the growth of the global smart healthcare products market in the coming years. Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global smart healthcare products market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, application and end user. Breakup by Product Type: Telemedicine Electronic Health Records mHealth Smart Pills and Syringes Smart RFID Cabinets Others Breakup by Application: Storage and Inventory Management Monitoring Treatment Others Breakup by End User: Hospitals Home Care Settings Others Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Allscripts Healthcare Solutions Inc, Capsule Technologies Inc., Cerner Corporation, Epic Systems Corporation, GE Healthcare Inc, Medical Information Technology Inc., Medtronic plc, NextGen Healthcare Inc., Olympus Corporation, Samsung Healthcare and Terumo Corporation. Key Questions Answered in This Report: How has the global smart healthcare products market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global smart healthcare products market? What are the key regional markets? What is the breakup of the market based on the product type? What is the breakup of the market based on the application? What is the breakup of the market based on the end user? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global smart healthcare products market and who are the key players? What is the degree of competition in the industry?

Table of Contents

  • 1 Preface

  • 2 Scope and Methodology

    • 2.1 Objectives of the Study
    • 2.2 Stakeholders
    • 2.3 Data Sources
      • 2.3.1 Primary Sources
      • 2.3.2 Secondary Sources
    • 2.4 Market Estimation
      • 2.4.1 Bottom-Up Approach
      • 2.4.2 Top-Down Approach
    • 2.5 Forecasting Methodology
  • 3 Executive Summary

  • 4 Introduction

    • 4.1 Overview
    • 4.2 Key Industry Trends
  • 5 Global Smart Healthcare Products Market

    • 5.1 Market Overview
    • 5.2 Market Performance
    • 5.3 Impact of COVID-19
    • 5.4 Market Forecast
  • 6 Market Breakup by Product Type

    • 6.1 Telemedicine
      • 6.1.1 Market Trends
      • 6.1.2 Market Forecast
    • 6.2 Electronic Health Records
      • 6.2.1 Market Trends
      • 6.2.2 Market Forecast
    • 6.3 mHealth
      • 6.3.1 Market Trends
      • 6.3.2 Market Forecast
    • 6.4 Smart Pills and Syringes
      • 6.4.1 Market Trends
      • 6.4.2 Market Forecast
    • 6.5 Smart RFID Cabinets
      • 6.5.1 Market Trends
      • 6.5.2 Market Forecast
    • 6.6 Others
      • 6.6.1 Market Trends
      • 6.6.2 Market Forecast
  • 7 Market Breakup by Application

    • 7.1 Storage and Inventory Management
      • 7.1.1 Market Trends
      • 7.1.2 Market Forecast
    • 7.2 Monitoring
      • 7.2.1 Market Trends
      • 7.2.2 Market Forecast
    • 7.3 Treatment
      • 7.3.1 Market Trends
      • 7.3.2 Market Forecast
    • 7.4 Others
      • 7.4.1 Market Trends
      • 7.4.2 Market Forecast
  • 8 Market Breakup by End User

    • 8.1 Hospitals
      • 8.1.1 Market Trends
      • 8.1.2 Market Forecast
    • 8.2 Home Care Settings
      • 8.2.1 Market Trends
      • 8.2.2 Market Forecast
    • 8.3 Others
      • 8.3.1 Market Trends
      • 8.3.2 Market Forecast
  • 9 Market Breakup by Region

    • 9.1 North America
      • 9.1.1 United States
        • 9.1.1.1 Market Trends
        • 9.1.1.2 Market Forecast
      • 9.1.2 Canada
        • 9.1.2.1 Market Trends
        • 9.1.2.2 Market Forecast
    • 9.2 Asia-Pacific
      • 9.2.1 China
        • 9.2.1.1 Market Trends
        • 9.2.1.2 Market Forecast
      • 9.2.2 Japan
        • 9.2.2.1 Market Trends
        • 9.2.2.2 Market Forecast
      • 9.2.3 India
        • 9.2.3.1 Market Trends
        • 9.2.3.2 Market Forecast
      • 9.2.4 South Korea
        • 9.2.4.1 Market Trends
        • 9.2.4.2 Market Forecast
      • 9.2.5 Australia
        • 9.2.5.1 Market Trends
        • 9.2.5.2 Market Forecast
      • 9.2.6 Indonesia
        • 9.2.6.1 Market Trends
        • 9.2.6.2 Market Forecast
      • 9.2.7 Others
        • 9.2.7.1 Market Trends
        • 9.2.7.2 Market Forecast
    • 9.3 Europe
      • 9.3.1 Germany
        • 9.3.1.1 Market Trends
        • 9.3.1.2 Market Forecast
      • 9.3.2 France
        • 9.3.2.1 Market Trends
        • 9.3.2.2 Market Forecast
      • 9.3.3 United Kingdom
        • 9.3.3.1 Market Trends
        • 9.3.3.2 Market Forecast
      • 9.3.4 Italy
        • 9.3.4.1 Market Trends
        • 9.3.4.2 Market Forecast
      • 9.3.5 Spain
        • 9.3.5.1 Market Trends
        • 9.3.5.2 Market Forecast
      • 9.3.6 Russia
        • 9.3.6.1 Market Trends
        • 9.3.6.2 Market Forecast
      • 9.3.7 Others
        • 9.3.7.1 Market Trends
        • 9.3.7.2 Market Forecast
    • 9.4 Latin America
      • 9.4.1 Brazil
        • 9.4.1.1 Market Trends
        • 9.4.1.2 Market Forecast
      • 9.4.2 Mexico
        • 9.4.2.1 Market Trends
        • 9.4.2.2 Market Forecast
      • 9.4.3 Others
        • 9.4.3.1 Market Trends
        • 9.4.3.2 Market Forecast
    • 9.5 Middle East and Africa
      • 9.5.1 Market Trends
      • 9.5.2 Market Breakup by Country
      • 9.5.3 Market Forecast
  • 10 SWOT Analysis

    • 10.1 Overview
    • 10.2 Strengths
    • 10.3 Weaknesses
    • 10.4 Opportunities
    • 10.5 Threats
  • 11 Value Chain Analysis

  • 12 Porters Five Forces Analysis

    • 12.1 Overview
    • 12.2 Bargaining Power of Buyers
    • 12.3 Bargaining Power of Suppliers
    • 12.4 Degree of Competition
    • 12.5 Threat of New Entrants
    • 12.6 Threat of Substitutes
  • 13 Price Analysis

  • 14 Competitive Landscape

    • 14.1 Market Structure
    • 14.2 Key Players
    • 14.3 Profiles of Key Players
      • 14.3.1 Abbott Laboratories
        • 14.3.1.1 Company Overview
        • 14.3.1.2 Product Portfolio
        • 14.3.1.3 Financials
        • 14.3.1.4 SWOT Analysis
      • 14.3.2 Allscripts Healthcare Solutions Inc
        • 14.3.2.1 Company Overview
        • 14.3.2.2 Product Portfolio
        • 14.3.2.3 Financials
        • 14.3.2.4 SWOT Analysis
      • 14.3.3 Capsule Technologies Inc
        • 14.3.3.1 Company Overview
        • 14.3.3.2 Product Portfolio
      • 14.3.4 Cerner Corporation
        • 14.3.4.1 Company Overview
        • 14.3.4.2 Product Portfolio
        • 14.3.4.3 SWOT Analysis
      • 14.3.5 Epic Systems Corporation
        • 14.3.5.1 Company Overview
        • 14.3.5.2 Product Portfolio
        • 14.3.5.3 SWOT Analysis
      • 14.3.6 GE Healthcare Inc
        • 14.3.6.1 Company Overview
        • 14.3.6.2 Product Portfolio
      • 14.3.7 Medical Information Technology Inc
        • 14.3.7.1 Company Overview
        • 14.3.7.2 Product Portfolio
      • 14.3.8 Medtronic plc
        • 14.3.8.1 Company Overview
        • 14.3.8.2 Product Portfolio
        • 14.3.8.3 Financials
        • 14.3.8.4 SWOT Analysis
      • 14.3.9 NextGen Healthcare Inc
        • 14.3.9.1 Company Overview
        • 14.3.9.2 Product Portfolio
        • 14.3.9.3 Financials
        • 14.3.9.4 SWOT Analysis
      • 14.3.10 Olympus Corporation
        • 14.3.10.1 Company Overview
        • 14.3.10.2 Product Portfolio
        • 14.3.10.3 Financials
        • 14.3.10.4 SWOT Analysis
      • 14.3.11 Samsung Healthcare
        • 14.3.11.1 Company Overview
        • 14.3.11.2 Product Portfolio
      • 14.3.12 Terumo Corporation
        • 14.3.12.1 Company Overview
        • 14.3.12.2 Product Portfolio
        • 14.3.12.3 Financials
        • 14.3.12.4 SWOT Analysis
USD 3,999 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.